Magical Trade
Thursday, August 11, 2022
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Magical Trade
No Result
View All Result
Home Trade News

Warren Buffett recently sold these top dividend stocks, but he could be dead wrong about them — here’s why they’re still worth buying

by
November 26, 2021
in Trade News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Warren Buffett recently sold these top dividend stocks, but he could be dead wrong about them — here’s why they’re still worth buying

Warren Buffett once said his favorite holding period is forever.

RELATED POSTS

Mocked by Everyone, Stock Rally Sits at Cusp of a Chart Landmark

Sanofi and GSK Lead $40 Billion Rout as Zantac Worries Mount

But that doesn’t mean he’s opposed to taking profits off the table when the price is right.

In Q3, Buffett’s holding company Berkshire Hathaway sold nearly $2 billion more in stocks than it purchased — the company’s fourth straight quarter of net selling.

Berkshire’s cash hoard now stands at a whopping $149.2 billion.

That said, no one is right 100% of the time. For average investors looking for high-quality companies, you might even find an opportunity in some of the stocks that Berkshire recently sold.

One (or several) of these names could be worth pouncing on with some of your extra cash — especially after Friday’s COVID-19 variant-fueled selloff.

Drugmakers

Ralf Liebhold / Shutterstock

The FDA will decide on Merck’s COVID-19 pill soon, but Buffett won’t be waiting for the news.

In Q3, Berkshire sold 9.16 million shares of the multinational pharmaceutical company, exiting its position entirely.

But the sale shouldn’t come as a complete surprise. Berkshire already unloaded millions of Merck shares in Q1 and Q2.

Buffett’s company also sold 6.13 million shares of drug giant AbbVie and 4.25 million shares of Bristol-Myers Squibb in Q3.

The COVID-19 pandemic gave investors a new reason to check out big pharmaceutical companies, but that doesn’t mean every stock in the segment has outperformed.

Year to date, AbbVie is up about 10%, Merck has gained roughly 2%, and Bristol-Myers is actually down 8%. Meanwhile, the S&P 500 is up nearly 25% in 2021.

But what really makes these drugmakers stand out? Dividends.

Each of the companies mentioned above currently provides an annual dividend yield of above 3%, much higher than the S&P 500’s 1.3%.

Financials

i viewfinder/Shutterstock

Financial stocks have had a solid bull run over the past year. And Buffett is cashing some chips in.

In Q3, Berkshire sold 276,108 shares of Mastercard, lowering its stake in the credit card giant by roughly 6%. It also cut its position in Visa by 4%.

Buffett also sold 2.47 million shares of U.S. Bancorp, the fifth-largest bank in the country. But it was just a 2% reduction in Berkshire’s stake.

Buffett isn’t exactly turning bearish on financials.

After all, Berkshire continues to hold more than one billion shares of Bank of America, a position with a current market value of roughly $45 billion. Berkshire also still owns approximately 151.6 million shares of American Express.

At the end of Q3, Bank of America and American Express were Berkshire’s second- and third-largest holdings, respectively.

These established financial firms pay regular quarterly dividends, which can be great for retail investors looking for passive income. And financials tend to do well in rising interest rate environments, making them a particularly timely opportunity.

These days, you can build your own blue-chip stock portfolio just by using some digital nickels and dimes.

Make passive income your priority

Andy Dean Photography/Shutterstock

Even if you’re not bullish on these dividend-paying stocks, generating regular income should be a top priority for risk-averse investors.

And you don’t have to limit yourself to the stock market to do that.

For instance, some popular investing services let you lock in a steady rental income stream by investing in premium commercial real estate properties — from R&D campuses in San Jose to industrial e-commerce warehouses in Baltimore.

You’ll gain exposure to high-end properties that big-time real estate moguls usually have access to.

And the best part? You’ll receive regular passive income in the form of cash distributions without any headaches or hassles.

This article provides information only and should not be construed as advice. It is provided without warranty of any kind.

ShareTweetPin

Related Posts

Mocked by Everyone, Stock Rally Sits at Cusp of a Chart Landmark

by
August 11, 2022
0

',panelEmptyTemplate=' {emptyPanelMsg} ',panelErrorTemplate=' {errorMsg} ',panelParentTemplate='',notifOnboardPromoTemplate='',EXPANDED_PANEL="expanded_panel",ERROR_PANEL="error_panel",NotificationView=function(){function e(n,t){classCallCheck(this,e);var i=this;i._config=n,i._panelNode=null,i._store=t}return createClass(e,[{key:"_generatePanelMarkup",value:function(e,n){var t=this._config,i=void 0,o=void 0;"undefined"!=typeof window&&(i=window.Notification&&"default"===window.Notification.permission,o=t.promos.bypassEligibleClassCheck||hasClass(document.body,t.promos.eligibleBodyClass));var r=t.promos.enableNotifOnboard&&i&&o?notifOnboardPromoTemplate:"";if(r){var s=t.promos.showYahooLogo?"":"yns-no-logo";r=r.replace("{notifOnboardBtnLabel}",t.promos.notifOnboardBtnLabel).replace("{notifOnboardMsg}",t.promos.notifOnboardMsg).replace("{subscriptionTopic}",t.promos.subscriptionTopic).replace("{noLogoClass}",s).replace("{promoLogo}",t.promos.promoLogo)}var a=n.newCount>t.panel.maxCount?n.newCount:"",c=t.panel.notificationCenterPath,l=c?"":constants.panelHideElement,d=t.panel.headerMsg?"":" "+constants.panelHideElement,u=c?constants.panelPaddingBtm:"",p=void 0;n.count?p=n.markup:p=panelEmptyTemplate.replace("{emptyPanelMsg}",t.panel.emptyPanelMsg);return e=e.replace("{notifMarkup}",p).replace("{promoMarkup}",r).replace("{hideClass}",l).replace("{notifCenterLink}",c).replace("{paddingClass}",u).replace("{headerMsg}",t.panel.headerMsg).replace("{hideHeaderClass}",d).replace(/{notificationCenterNavMsg}/g,t.panel.notificationCenterNavMsg).replace(/{newCount}/g,a)}},{key:"render",value:function(e,n){var t=this;if(t._panelNode){var i=void...

Sanofi and GSK Lead $40 Billion Rout as Zantac Worries Mount

by
August 11, 2022
0

',panelEmptyTemplate=' {emptyPanelMsg} ',panelErrorTemplate=' {errorMsg} ',panelParentTemplate='',notifOnboardPromoTemplate='',EXPANDED_PANEL="expanded_panel",ERROR_PANEL="error_panel",NotificationView=function(){function e(n,t){classCallCheck(this,e);var i=this;i._config=n,i._panelNode=null,i._store=t}return createClass(e,[{key:"_generatePanelMarkup",value:function(e,n){var t=this._config,i=void 0,o=void 0;"undefined"!=typeof window&&(i=window.Notification&&"default"===window.Notification.permission,o=t.promos.bypassEligibleClassCheck||hasClass(document.body,t.promos.eligibleBodyClass));var r=t.promos.enableNotifOnboard&&i&&o?notifOnboardPromoTemplate:"";if(r){var s=t.promos.showYahooLogo?"":"yns-no-logo";r=r.replace("{notifOnboardBtnLabel}",t.promos.notifOnboardBtnLabel).replace("{notifOnboardMsg}",t.promos.notifOnboardMsg).replace("{subscriptionTopic}",t.promos.subscriptionTopic).replace("{noLogoClass}",s).replace("{promoLogo}",t.promos.promoLogo)}var a=n.newCount>t.panel.maxCount?n.newCount:"",c=t.panel.notificationCenterPath,l=c?"":constants.panelHideElement,d=t.panel.headerMsg?"":" "+constants.panelHideElement,u=c?constants.panelPaddingBtm:"",p=void 0;n.count?p=n.markup:p=panelEmptyTemplate.replace("{emptyPanelMsg}",t.panel.emptyPanelMsg);return e=e.replace("{notifMarkup}",p).replace("{promoMarkup}",r).replace("{hideClass}",l).replace("{notifCenterLink}",c).replace("{paddingClass}",u).replace("{headerMsg}",t.panel.headerMsg).replace("{hideHeaderClass}",d).replace(/{notificationCenterNavMsg}/g,t.panel.notificationCenterNavMsg).replace(/{newCount}/g,a)}},{key:"render",value:function(e,n){var t=this;if(t._panelNode){var i=void...

Switch from gas boosts oil demand, but economic headwinds loom — IEA

by
August 11, 2022
0

Speaking to CNBC on Monday, the executive director of the International Energy Agency spoke about the intricacies of the energy...

Thai central bank governor says there’s no need to ‘undertake heroically large rate hikes’

by
August 11, 2022
0

The Bank of Thailand's move to hike interest rates by 25 basis point to 0.75% was a "gradual and measured...

This CEO developed what’s been dubbed Asia’s Tesla of scooters. Here are his top tips

by
August 11, 2022
0

Horace Luke isn't a fan of the word "no." "If I ask the first time I can do something...

Next Post

WHO labels new Covid strain, named omicron, a 'variant of concern', citing possible increased reinfection risk

Dow tumbles 900 points for worst day of year on fears of new Covid variant, S&P 500 drops 2%

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Fund manager believes FAANG is dead — says now it’s all about MANTA

    0 shares
    Share 0 Tweet 0
  • Bank of America names its top global tech stocks — including one it says has upside of 100%

    0 shares
    Share 0 Tweet 0
  • ‘Conviction sell’: UBS says avoid these global stocks amid rising headwinds

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs "Will Higher Rates Put Out the Housing Fire?"

    0 shares
    Share 0 Tweet 0
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.magicaltrade.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.magicaltrade.net